Estrone recalls
The FDA has published 2 recalls involving Estrone since 2017. The latest was reported on 28 Feb 2018. Most were for potency & assay. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2017
Last 12 months0reported
Class I00% of total
Ongoing0latest 28 Feb 2018
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why estrone is recalled
Companies
By year
All estrone recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Estrone USP for prescription compounding recalled | American Pharmaceutical Ingredients | Potency & Assay | Nationwide |
| Drug | CLASS II | Estrone recalled by American Pharmaceutical | American Pharmaceutical Ingredients | Manufacturing (CGMP) Deviations | 6 states |
Should you stop taking Estrone?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.